Accretion Nutraveda Ltd

BSE: 544694 · Pharmaceuticals & Biotechnology · 12 announcements

Share price: ₹304.50
Market cap: ₹220.5 Cr
Revenue (annual): ₹33.60 Cr
Net profit (annual): ₹5.07 Cr
P/E (TTM): 43.5×Sector 47.3×
Promoter holding: 73.48%+0.00% QoQ
FII holding: 1.08%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Annual General Meeting 3 Other Announcement 1 Business Update 1 Board Meeting Outcome 1 Annual Report 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

1 announcement with these filters

1 Sep 2026 12:39 IST BSE

Board Meeting Outcome

Accretion Nutraveda Board Meeting Outcome

Accretion Nutraveda's board approved altering its Object Clause to include nutraceuticals and hospitals. The board also proposed increasing borrowing limits and advancing loans to related entities.

Read the filing ↗